BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Chugai Pharma USA, LLC. 

One Crossroads Drive
Building A, 2nd Floor
Bedminster  New Jersey  07921-2688  U.S.A.
Phone: 908-947-2700 Fax: 908-947-2662


SEARCH JOBS

Company Overview:
As a member of the Chugai-Roche Group, Chugai Pharma USA LLC (CPUSA), founded in 1995 in San Diego, CA and currently based in Bedminster, NJ, is committed to the timely development and commercialization of safe and effective drugs for the North American market place. For more than 70 years our parent company, Chugai Pharmaceutical Co. Ltd., has provided high quality, safe and effective drugs to the Japanese and global market place, a heritage that will be continued in North America by CPUSA. As a result of our alliance with F. Hoffmann-La Roche Ltd. in 2002, CPUSA enjoys the resources of a large global conglomerate while preserving the focus and agility of a small local company. CPUSA maintains the same therapeutic focuses as our parent, currently working mainly in the areas of treatments for cardiovascular disease, cancer, metabolic disease and diseases involving inflammation. We are a company of collaborative, committed, talented and experienced people with an unwavering dedication to quality and the highest environmental and ethical standards. We all take great pride in bringing new medicines to market for the benefit of those in need.

Corporate Mission:
At CPUSA, our mission is to contribute local experience, expertise and flexibility to Chugai’s global effort to rapidly develop and market high quality, innovative therapies for the benefit of human health and the maximization of shareholder value; and, to create additional value by emphasizing advancements in specialty indications for the North American market.

Key Personnel:
David J. Mazzo, PhD; President and CEO
Ellen McDonald; Senior Vice President, Business Operations
Nicholas Pelliccione, PhD; Senior Vice President, Regulatory and Pharmaceutical Sciences
Peter Powchik, MD; Senior Vice President, Clinical Development and Chief Medical Officer
Andrew Rackear, JD; Vice President and General Counsel
Holly Wimer; Vice President, Human Resources

Last Updated: 06-01-2006

 Key Statistics


Email:
Ownership: Subsidiary

Web Site: Chugai Pharma USA, LLC.
Employees: 70
Symbol: 
 



Industry
Biotechnology






 Company News
Chugai Pharmaceutical Co., Ltd. (Japan) To Jointly Establish "Forerunner Pharma Research Co., Ltd." With Mitsui & Co., Ltd And CIEA 10/19/2005 5:13:08 PM    More...
Cambridge Antibody Technology Group PLC (CATG) Legal Action With Abbott: Abbott Granted Permission To Appeal 10/19/2005 5:13:05 PM    More...
Roche (RHHBY) Files Supplemental New Drug Application To Extend Prophylaxis Indication For Tamiflu(R) To Patients Between 1-12 Years Of Age 10/19/2005 5:13:04 PM    More...
Chugai Pharmaceutical Co., Ltd. (Japan)'s Antitumor Agent Natulan Now Available For Treating Glioma 10/19/2005 5:12:53 PM    More...
Roche (RHHBY) Release: New Treatment Guidelines Recommend VALCYTE(R) For AIDS-Related CMV Retinitis 10/19/2005 5:12:35 PM    More...
Inpharmatica Announces PharmaCarta(TM) Partnership With Pfizer Inc. (PFE) 10/19/2005 5:12:32 PM    More...
Cerus Corporation (CERS) Acquires Additional Rights To Mesothelin Cancer Antigen From Chugai Pharmaceutical Co., Ltd. (Japan) 10/19/2005 5:12:31 PM    More...
Inpharmatica Announces Chematica(TM) Agreement With Novartis (NVS) 10/19/2005 5:12:26 PM    More...
Mikasa Seiyaku To Dissolve Partnership With Chugai Pharmaceutical Co., Ltd. (Japan) 10/19/2005 5:12:25 PM    More...
Xencor And Chugai Pharmaceutical Co., Ltd. (Japan) Initiate Partnership For Optimized Antibodies; Chugai Licenses Xencor's XmAb Technology To Enhance Antibody Efficacy 10/19/2005 5:12:04 PM    More...
12

//-->